Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Central Nervous System (CNS) therapeutics Market Research Reports

Titlepublishedprice

Spinal Cord Injury - Pipeline Review, H1 2017

By Global Markets Direct
"...... al cord. SCI can lead to loss or impaired function resulting in reduced mobility or feeling. It is usually caused by trauma, transverse myelitis, polio, spina bifida or Friedreich's ataxia. Signs and symptoms of spinal cord injury include extreme bac......"
23-May-2017$2000

Global Spinal Cord Partnering 2010 to 2017

By Current Partnering
"...... report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. Β• Trends in partnering deals Β• Top deals by value Β• Deals listed by company A-Z, indus......"
01-Apr-2017$1495

Global Neuropathy Partnering 2010 to 2017

By Current Partnering
"...... port provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. Β• Trends in partnering deals Β• Top deals by value Β• Deals listed by company A-Z, industry......"
01-Apr-2017$1495

Encephalomyelitis - Pipeline Review, H1 2017

By Global Markets Direct
"...... ape. Encephalomyelitis is an inflammation of the brain and spinal cord. Encephalomyelitis can be caused by a variety of conditions that lead to irritation of the brain and spinal cord. Among the common causes of encephalomyelitis are vir......"
15-Mar-2017$2000

Bacterial (Pyogenic) Meningitis-Pipeline Insights, 2017

By Delve Insight
"...... uding Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, pate......"
01-Jan-2017$1250

Meningitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... erstand the market and pipeline status of the drugs around the Meningitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides......"
01-Jan-2017$2000

Spinal Cord Disorders-Pipeline Insights, 2017

By Delve Insight
"...... -clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA d......"
01-Jan-2017$1250

Spinal Stenosis-Pipeline Insights, 2017

By Delve Insight
"...... ND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations ......"
01-Jan-2017$1250

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)-Pipeline Insights, 2017

By Delve Insight
"...... uct profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licen......"
01-Jan-2017$1250

Spinal Cord Injury-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... Report is to understand the market and pipeline status of the drugs around the Spinal Cord Injury to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveI......"
01-Jan-2017$2000

Avail upto 25% Discount on below Publisher Reports.